Announcements
Trials
Browse
Landscape
Eligibility
Clinical Trials
2 trials
Recent
Start date
Enrollment
Interventional
×
Has announcements
×
mirvetuximab soravtansine
×
Clear all
Filters
3
NCT04209855
2025-08-27
MIRASOL
AbbVie
Phase 3
Completed
453 enrolled
18 charts
1 FDA
NCT04296890
2024-08-07
SORAYA
ImmunoGen, Inc.
Phase 3
Completed
106 enrolled
14 charts
1 FDA